nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—ABCB1—ulcerative colitis	0.101	1	CbGaD
Bosutinib—Vandetanib—RIPK2—ulcerative colitis	0.00629	0.794	CrCbGaD
Bosutinib—CYP3A4—Budesonide—ulcerative colitis	0.00549	0.147	CbGbCtD
Bosutinib—ABCB1—Methylprednisolone—ulcerative colitis	0.00409	0.11	CbGbCtD
Bosutinib—WEE2—lymphoid tissue—ulcerative colitis	0.00331	0.0162	CbGeAlD
Bosutinib—ABCB1—Betamethasone—ulcerative colitis	0.00266	0.0713	CbGbCtD
Bosutinib—ABCB1—Prednisolone—ulcerative colitis	0.00262	0.0704	CbGbCtD
Bosutinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00249	0.0667	CbGbCtD
Bosutinib—ABCB1—Prednisone—ulcerative colitis	0.00248	0.0665	CbGbCtD
Bosutinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00245	0.0657	CbGbCtD
Bosutinib—CYP3A4—Nicotine—ulcerative colitis	0.00239	0.064	CbGbCtD
Bosutinib—BMX—epithelium—ulcerative colitis	0.00215	0.0105	CbGeAlD
Bosutinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00214	0.0574	CbGbCtD
Bosutinib—CLK3—smooth muscle tissue—ulcerative colitis	0.00207	0.0101	CbGeAlD
Bosutinib—CDK2—epithelium—ulcerative colitis	0.00196	0.00955	CbGeAlD
Bosutinib—CDK2—smooth muscle tissue—ulcerative colitis	0.00188	0.0092	CbGeAlD
Bosutinib—CYP3A4—Triamcinolone—ulcerative colitis	0.00186	0.0498	CbGbCtD
Bosutinib—DMPK—epithelium—ulcerative colitis	0.00186	0.00906	CbGeAlD
Bosutinib—DMPK—smooth muscle tissue—ulcerative colitis	0.00179	0.00873	CbGeAlD
Bosutinib—PRKCQ—lymphoid tissue—ulcerative colitis	0.00176	0.00861	CbGeAlD
Bosutinib—STK33—digestive system—ulcerative colitis	0.00172	0.00839	CbGeAlD
Bosutinib—FRK—lymphoid tissue—ulcerative colitis	0.00169	0.00828	CbGeAlD
Bosutinib—PLK2—smooth muscle tissue—ulcerative colitis	0.00166	0.00811	CbGeAlD
Bosutinib—BLK—lymphoid tissue—ulcerative colitis	0.00164	0.00799	CbGeAlD
Bosutinib—CLK3—digestive system—ulcerative colitis	0.00163	0.00798	CbGeAlD
Bosutinib—EPHB2—lymphoid tissue—ulcerative colitis	0.00162	0.0079	CbGeAlD
Bosutinib—EPHB2—digestive system—ulcerative colitis	0.0016	0.0078	CbGeAlD
Bosutinib—CYP3A4—Betamethasone—ulcerative colitis	0.00159	0.0427	CbGbCtD
Bosutinib—CYP3A4—Prednisolone—ulcerative colitis	0.00157	0.0422	CbGbCtD
Bosutinib—TXK—lymphoid tissue—ulcerative colitis	0.00157	0.00765	CbGeAlD
Bosutinib—SRMS—digestive system—ulcerative colitis	0.00156	0.00763	CbGeAlD
Bosutinib—ABCB1—Dexamethasone—ulcerative colitis	0.00155	0.0415	CbGbCtD
Bosutinib—SYK—lymphoid tissue—ulcerative colitis	0.00152	0.00742	CbGeAlD
Bosutinib—CDK2—lymphoid tissue—ulcerative colitis	0.00151	0.00735	CbGeAlD
Bosutinib—SYK—digestive system—ulcerative colitis	0.0015	0.00733	CbGeAlD
Bosutinib—STK26—lymphoid tissue—ulcerative colitis	0.00149	0.00729	CbGeAlD
Bosutinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00149	0.04	CbGbCtD
Bosutinib—CDK2—digestive system—ulcerative colitis	0.00149	0.00726	CbGeAlD
Bosutinib—CYP3A4—Prednisone—ulcerative colitis	0.00149	0.0398	CbGbCtD
Bosutinib—STK26—digestive system—ulcerative colitis	0.00147	0.0072	CbGeAlD
Bosutinib—ERBB4—epithelium—ulcerative colitis	0.00146	0.00711	CbGeAlD
Bosutinib—ROCK1—epithelium—ulcerative colitis	0.00144	0.00701	CbGeAlD
Bosutinib—DMPK—digestive system—ulcerative colitis	0.00141	0.0069	CbGeAlD
Bosutinib—WEE1—digestive system—ulcerative colitis	0.00141	0.0069	CbGeAlD
Bosutinib—ROCK1—smooth muscle tissue—ulcerative colitis	0.00138	0.00676	CbGeAlD
Bosutinib—STK25—lymphoid tissue—ulcerative colitis	0.00136	0.00667	CbGeAlD
Bosutinib—STK25—digestive system—ulcerative colitis	0.00135	0.00658	CbGeAlD
Bosutinib—BMPR2—smooth muscle tissue—ulcerative colitis	0.00134	0.00656	CbGeAlD
Bosutinib—PLK2—lymphoid tissue—ulcerative colitis	0.00133	0.00648	CbGeAlD
Bosutinib—TLK1—liver—ulcerative colitis	0.00132	0.00643	CbGeAlD
Bosutinib—PLK2—digestive system—ulcerative colitis	0.00131	0.0064	CbGeAlD
Bosutinib—PRKCQ—liver—ulcerative colitis	0.0013	0.00634	CbGeAlD
Bosutinib—MAP2K1—epithelium—ulcerative colitis	0.0013	0.00633	CbGeAlD
Bosutinib—MAP4K4—smooth muscle tissue—ulcerative colitis	0.00129	0.00632	CbGeAlD
Bosutinib—SIK2—liver—ulcerative colitis	0.00128	0.00625	CbGeAlD
Bosutinib—STK4—lymphoid tissue—ulcerative colitis	0.00127	0.0062	CbGeAlD
Bosutinib—STK4—digestive system—ulcerative colitis	0.00125	0.00612	CbGeAlD
Bosutinib—MAP2K1—smooth muscle tissue—ulcerative colitis	0.00125	0.0061	CbGeAlD
Bosutinib—FRK—liver—ulcerative colitis	0.00125	0.00609	CbGeAlD
Bosutinib—CSK—smooth muscle tissue—ulcerative colitis	0.00124	0.00606	CbGeAlD
Bosutinib—CSNK1A1—smooth muscle tissue—ulcerative colitis	0.00123	0.00602	CbGeAlD
Bosutinib—CLK3—liver—ulcerative colitis	0.00122	0.00595	CbGeAlD
Bosutinib—FER—lymphoid tissue—ulcerative colitis	0.0012	0.00586	CbGeAlD
Bosutinib—TYRO3—lymphoid tissue—ulcerative colitis	0.0012	0.00586	CbGeAlD
Bosutinib—ALK—lymphoid tissue—ulcerative colitis	0.0012	0.00586	CbGeAlD
Bosutinib—LYN—lymphoid tissue—ulcerative colitis	0.00119	0.00583	CbGeAlD
Bosutinib—CASK—liver—ulcerative colitis	0.00119	0.00581	CbGeAlD
Bosutinib—ALK—digestive system—ulcerative colitis	0.00118	0.00578	CbGeAlD
Bosutinib—EPHA5—digestive system—ulcerative colitis	0.00118	0.00578	CbGeAlD
Bosutinib—EIF2AK1—liver—ulcerative colitis	0.00118	0.00575	CbGeAlD
Bosutinib—MAP4K1—lymphoid tissue—ulcerative colitis	0.00117	0.00574	CbGeAlD
Bosutinib—BTK—lymphoid tissue—ulcerative colitis	0.00117	0.00571	CbGeAlD
Bosutinib—PTK2B—smooth muscle tissue—ulcerative colitis	0.00116	0.00567	CbGeAlD
Bosutinib—ERBB3—epithelium—ulcerative colitis	0.00114	0.00559	CbGeAlD
Bosutinib—FES—liver—ulcerative colitis	0.00114	0.00557	CbGeAlD
Bosutinib—VRK2—liver—ulcerative colitis	0.00114	0.00557	CbGeAlD
Bosutinib—MAP4K2—lymphoid tissue—ulcerative colitis	0.00114	0.00555	CbGeAlD
Bosutinib—TNIK—liver—ulcerative colitis	0.00112	0.00546	CbGeAlD
Bosutinib—PTK2—epithelium—ulcerative colitis	0.00111	0.00542	CbGeAlD
Bosutinib—CDK2—liver—ulcerative colitis	0.00111	0.00541	CbGeAlD
Bosutinib—ROCK1—lymphoid tissue—ulcerative colitis	0.00111	0.0054	CbGeAlD
Bosutinib—MAP2K2—smooth muscle tissue—ulcerative colitis	0.0011	0.00537	CbGeAlD
Bosutinib—STK26—liver—ulcerative colitis	0.0011	0.00536	CbGeAlD
Bosutinib—ROCK1—digestive system—ulcerative colitis	0.00109	0.00534	CbGeAlD
Bosutinib—MAP3K7—smooth muscle tissue—ulcerative colitis	0.00108	0.00528	CbGeAlD
Bosutinib—BMPR2—lymphoid tissue—ulcerative colitis	0.00107	0.00525	CbGeAlD
Bosutinib—PTK2—smooth muscle tissue—ulcerative colitis	0.00107	0.00522	CbGeAlD
Bosutinib—RPS6KB1—epithelium—ulcerative colitis	0.00107	0.00522	CbGeAlD
Bosutinib—BMPR2—digestive system—ulcerative colitis	0.00106	0.00518	CbGeAlD
Bosutinib—MERTK—lymphoid tissue—ulcerative colitis	0.00105	0.00515	CbGeAlD
Bosutinib—EPHB3—digestive system—ulcerative colitis	0.00105	0.00514	CbGeAlD
Bosutinib—WEE1—liver—ulcerative colitis	0.00105	0.00514	CbGeAlD
Bosutinib—DMPK—liver—ulcerative colitis	0.00105	0.00514	CbGeAlD
Bosutinib—IRAK1—smooth muscle tissue—ulcerative colitis	0.00105	0.00512	CbGeAlD
Bosutinib—MAP4K4—lymphoid tissue—ulcerative colitis	0.00103	0.00505	CbGeAlD
Bosutinib—RPS6KB1—smooth muscle tissue—ulcerative colitis	0.00103	0.00503	CbGeAlD
Bosutinib—BCR—lymphoid tissue—ulcerative colitis	0.00103	0.00501	CbGeAlD
Bosutinib—MAP4K4—digestive system—ulcerative colitis	0.00102	0.00499	CbGeAlD
Bosutinib—AXL—smooth muscle tissue—ulcerative colitis	0.00102	0.00498	CbGeAlD
Bosutinib—EPHB4—epithelium—ulcerative colitis	0.00101	0.00493	CbGeAlD
Bosutinib—STK25—liver—ulcerative colitis	0.001	0.0049	CbGeAlD
Bosutinib—MAP2K1—lymphoid tissue—ulcerative colitis	0.000999	0.00488	CbGeAlD
Bosutinib—CSK—lymphoid tissue—ulcerative colitis	0.000992	0.00485	CbGeAlD
Bosutinib—EPHA2—epithelium—ulcerative colitis	0.000991	0.00484	CbGeAlD
Bosutinib—MAP2K1—digestive system—ulcerative colitis	0.000987	0.00482	CbGeAlD
Bosutinib—CSNK1A1—lymphoid tissue—ulcerative colitis	0.000986	0.00481	CbGeAlD
Bosutinib—CSK—digestive system—ulcerative colitis	0.00098	0.00479	CbGeAlD
Bosutinib—HCK—lymphoid tissue—ulcerative colitis	0.00098	0.00478	CbGeAlD
Bosutinib—CLK1—lymphoid tissue—ulcerative colitis	0.00098	0.00478	CbGeAlD
Bosutinib—PLK2—liver—ulcerative colitis	0.000976	0.00477	CbGeAlD
Bosutinib—CSNK1A1—digestive system—ulcerative colitis	0.000974	0.00476	CbGeAlD
Bosutinib—EPHB4—smooth muscle tissue—ulcerative colitis	0.000974	0.00475	CbGeAlD
Bosutinib—SIK3—liver—ulcerative colitis	0.00097	0.00474	CbGeAlD
Bosutinib—HCK—digestive system—ulcerative colitis	0.000968	0.00473	CbGeAlD
Bosutinib—CLK1—digestive system—ulcerative colitis	0.000968	0.00473	CbGeAlD
Bosutinib—FYN—smooth muscle tissue—ulcerative colitis	0.000953	0.00466	CbGeAlD
Bosutinib—CAMK2G—digestive system—ulcerative colitis	0.00095	0.00464	CbGeAlD
Bosutinib—STK4—liver—ulcerative colitis	0.000934	0.00456	CbGeAlD
Bosutinib—MAP4K5—smooth muscle tissue—ulcerative colitis	0.000932	0.00455	CbGeAlD
Bosutinib—PTK2B—lymphoid tissue—ulcerative colitis	0.000929	0.00454	CbGeAlD
Bosutinib—CYP3A4—Dexamethasone—ulcerative colitis	0.000927	0.0249	CbGbCtD
Bosutinib—CAMK1D—liver—ulcerative colitis	0.000923	0.00451	CbGeAlD
Bosutinib—PTK2B—digestive system—ulcerative colitis	0.000917	0.00448	CbGeAlD
Bosutinib—STK24—liver—ulcerative colitis	0.000912	0.00445	CbGeAlD
Bosutinib—CSNK1E—digestive system—ulcerative colitis	0.000902	0.00441	CbGeAlD
Bosutinib—SIK1—lymphoid tissue—ulcerative colitis	0.000899	0.00439	CbGeAlD
Bosutinib—IRAK4—lymphoid tissue—ulcerative colitis	0.000899	0.00439	CbGeAlD
Bosutinib—FER—liver—ulcerative colitis	0.000882	0.00431	CbGeAlD
Bosutinib—ERBB3—lymphoid tissue—ulcerative colitis	0.000881	0.00431	CbGeAlD
Bosutinib—MAP2K2—lymphoid tissue—ulcerative colitis	0.000879	0.00429	CbGeAlD
Bosutinib—LYN—liver—ulcerative colitis	0.000878	0.00429	CbGeAlD
Bosutinib—MAP3K2—lymphoid tissue—ulcerative colitis	0.000873	0.00426	CbGeAlD
Bosutinib—ERBB3—digestive system—ulcerative colitis	0.000871	0.00425	CbGeAlD
Bosutinib—ULK3—digestive system—ulcerative colitis	0.000869	0.00424	CbGeAlD
Bosutinib—MAP2K2—digestive system—ulcerative colitis	0.000869	0.00424	CbGeAlD
Bosutinib—YES1—smooth muscle tissue—ulcerative colitis	0.00086	0.0042	CbGeAlD
Bosutinib—BTK—liver—ulcerative colitis	0.00086	0.0042	CbGeAlD
Bosutinib—SRC—epithelium—ulcerative colitis	0.000859	0.0042	CbGeAlD
Bosutinib—PTK2—lymphoid tissue—ulcerative colitis	0.000855	0.00418	CbGeAlD
Bosutinib—TBK1—lymphoid tissue—ulcerative colitis	0.000855	0.00418	CbGeAlD
Bosutinib—TNK2—liver—ulcerative colitis	0.000848	0.00414	CbGeAlD
Bosutinib—PTK2—digestive system—ulcerative colitis	0.000845	0.00412	CbGeAlD
Bosutinib—TBK1—digestive system—ulcerative colitis	0.000845	0.00412	CbGeAlD
Bosutinib—MAP4K2—liver—ulcerative colitis	0.000836	0.00408	CbGeAlD
Bosutinib—SRC—smooth muscle tissue—ulcerative colitis	0.000828	0.00404	CbGeAlD
Bosutinib—STK3—liver—ulcerative colitis	0.000825	0.00403	CbGeAlD
Bosutinib—RPS6KB1—lymphoid tissue—ulcerative colitis	0.000823	0.00402	CbGeAlD
Bosutinib—FGR—lymphoid tissue—ulcerative colitis	0.000818	0.00399	CbGeAlD
Bosutinib—AXL—lymphoid tissue—ulcerative colitis	0.000814	0.00398	CbGeAlD
Bosutinib—ROCK1—liver—ulcerative colitis	0.000814	0.00398	CbGeAlD
Bosutinib—RPS6KB1—digestive system—ulcerative colitis	0.000812	0.00397	CbGeAlD
Bosutinib—FGR—digestive system—ulcerative colitis	0.000808	0.00394	CbGeAlD
Bosutinib—BMPR2—liver—ulcerative colitis	0.000791	0.00386	CbGeAlD
Bosutinib—STK36—liver—ulcerative colitis	0.000784	0.00383	CbGeAlD
Bosutinib—MERTK—liver—ulcerative colitis	0.000775	0.00379	CbGeAlD
Bosutinib—EPHB4—digestive system—ulcerative colitis	0.000769	0.00375	CbGeAlD
Bosutinib—EPHA2—lymphoid tissue—ulcerative colitis	0.000763	0.00373	CbGeAlD
Bosutinib—FYN—lymphoid tissue—ulcerative colitis	0.000762	0.00372	CbGeAlD
Bosutinib—MAP4K4—liver—ulcerative colitis	0.000761	0.00372	CbGeAlD
Bosutinib—BCR—liver—ulcerative colitis	0.000756	0.00369	CbGeAlD
Bosutinib—NUAK2—liver—ulcerative colitis	0.000756	0.00369	CbGeAlD
Bosutinib—EPHA2—digestive system—ulcerative colitis	0.000754	0.00368	CbGeAlD
Bosutinib—FYN—digestive system—ulcerative colitis	0.000753	0.00368	CbGeAlD
Bosutinib—MAP3K12—liver—ulcerative colitis	0.00075	0.00366	CbGeAlD
Bosutinib—MAP4K5—lymphoid tissue—ulcerative colitis	0.000745	0.00364	CbGeAlD
Bosutinib—CSF1R—smooth muscle tissue—ulcerative colitis	0.000743	0.00363	CbGeAlD
Bosutinib—MAP2K1—liver—ulcerative colitis	0.000735	0.00359	CbGeAlD
Bosutinib—STK35—liver—ulcerative colitis	0.000735	0.00359	CbGeAlD
Bosutinib—CSK—liver—ulcerative colitis	0.00073	0.00357	CbGeAlD
Bosutinib—CSNK1A1—liver—ulcerative colitis	0.000725	0.00354	CbGeAlD
Bosutinib—HCK—liver—ulcerative colitis	0.000721	0.00352	CbGeAlD
Bosutinib—CLK1—liver—ulcerative colitis	0.000721	0.00352	CbGeAlD
Bosutinib—ABL2—liver—ulcerative colitis	0.000716	0.0035	CbGeAlD
Bosutinib—BMP2K—liver—ulcerative colitis	0.000708	0.00346	CbGeAlD
Bosutinib—CAMK2G—liver—ulcerative colitis	0.000708	0.00346	CbGeAlD
Bosutinib—LRRK2—liver—ulcerative colitis	0.000701	0.00342	CbGeAlD
Bosutinib—EGFR—liver—ulcerative colitis	0.000699	0.00341	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Budesonide—ulcerative colitis	0.000699	0.0982	CbGdCrCtD
Bosutinib—YES1—lymphoid tissue—ulcerative colitis	0.000688	0.00336	CbGeAlD
Bosutinib—PDGFRB—epithelium—ulcerative colitis	0.000684	0.00334	CbGeAlD
Bosutinib—PTK2B—liver—ulcerative colitis	0.000683	0.00334	CbGeAlD
Bosutinib—STK10—lymphoid tissue—ulcerative colitis	0.000682	0.00333	CbGeAlD
Bosutinib—YES1—digestive system—ulcerative colitis	0.000679	0.00332	CbGeAlD
Bosutinib—TAOK3—lymphoid tissue—ulcerative colitis	0.000679	0.00332	CbGeAlD
Bosutinib—STK10—digestive system—ulcerative colitis	0.000673	0.00329	CbGeAlD
Bosutinib—CSNK1E—liver—ulcerative colitis	0.000672	0.00328	CbGeAlD
Bosutinib—TAOK3—digestive system—ulcerative colitis	0.000671	0.00328	CbGeAlD
Bosutinib—SIK1—liver—ulcerative colitis	0.000662	0.00323	CbGeAlD
Bosutinib—IRAK4—liver—ulcerative colitis	0.000662	0.00323	CbGeAlD
Bosutinib—SRC—lymphoid tissue—ulcerative colitis	0.000662	0.00323	CbGeAlD
Bosutinib—PDGFRB—smooth muscle tissue—ulcerative colitis	0.000659	0.00322	CbGeAlD
Bosutinib—SRC—digestive system—ulcerative colitis	0.000654	0.00319	CbGeAlD
Bosutinib—ERBB3—liver—ulcerative colitis	0.000649	0.00317	CbGeAlD
Bosutinib—MAP2K2—liver—ulcerative colitis	0.000647	0.00316	CbGeAlD
Bosutinib—ULK3—liver—ulcerative colitis	0.000647	0.00316	CbGeAlD
Bosutinib—MAP3K2—liver—ulcerative colitis	0.000642	0.00314	CbGeAlD
Bosutinib—MAP3K7—liver—ulcerative colitis	0.000636	0.00311	CbGeAlD
Bosutinib—PTK2—liver—ulcerative colitis	0.000629	0.00307	CbGeAlD
Bosutinib—TBK1—liver—ulcerative colitis	0.000629	0.00307	CbGeAlD
Bosutinib—IRAK1—liver—ulcerative colitis	0.000617	0.00301	CbGeAlD
Bosutinib—RPS6KB1—liver—ulcerative colitis	0.000605	0.00296	CbGeAlD
Bosutinib—LCK—liver—ulcerative colitis	0.000602	0.00294	CbGeAlD
Bosutinib—FGR—liver—ulcerative colitis	0.000602	0.00294	CbGeAlD
Bosutinib—AXL—liver—ulcerative colitis	0.000599	0.00293	CbGeAlD
Bosutinib—CSF1R—lymphoid tissue—ulcerative colitis	0.000594	0.0029	CbGeAlD
Bosutinib—ABL1—smooth muscle tissue—ulcerative colitis	0.000587	0.00287	CbGeAlD
Bosutinib—CSF1R—digestive system—ulcerative colitis	0.000587	0.00287	CbGeAlD
Bosutinib—SLK—liver—ulcerative colitis	0.000577	0.00282	CbGeAlD
Bosutinib—EPHB4—liver—ulcerative colitis	0.000573	0.0028	CbGeAlD
Bosutinib—Vandetanib—ALB—ulcerative colitis	0.000571	0.0721	CrCbGaD
Bosutinib—ERBB3—Methyldopa—Mesalazine—ulcerative colitis	0.00057	0.0802	CbGdCrCtD
Bosutinib—EPHA2—liver—ulcerative colitis	0.000562	0.00274	CbGeAlD
Bosutinib—FYN—liver—ulcerative colitis	0.000561	0.00274	CbGeAlD
Bosutinib—MAP4K5—liver—ulcerative colitis	0.000548	0.00268	CbGeAlD
Bosutinib—MAP3K3—liver—ulcerative colitis	0.000548	0.00268	CbGeAlD
Bosutinib—Gefitinib—ALB—ulcerative colitis	0.000542	0.0685	CrCbGaD
Bosutinib—PDGFRB—lymphoid tissue—ulcerative colitis	0.000527	0.00257	CbGeAlD
Bosutinib—PDGFRB—digestive system—ulcerative colitis	0.00052	0.00254	CbGeAlD
Bosutinib—Gefitinib—ABCB1—ulcerative colitis	0.000518	0.0653	CrCbGaD
Bosutinib—YES1—liver—ulcerative colitis	0.000506	0.00247	CbGeAlD
Bosutinib—STK10—liver—ulcerative colitis	0.000502	0.00245	CbGeAlD
Bosutinib—TAOK3—liver—ulcerative colitis	0.0005	0.00244	CbGeAlD
Bosutinib—SRC—liver—ulcerative colitis	0.000487	0.00238	CbGeAlD
Bosutinib—ABL1—lymphoid tissue—ulcerative colitis	0.00047	0.00229	CbGeAlD
Bosutinib—ABL1—digestive system—ulcerative colitis	0.000464	0.00227	CbGeAlD
Bosutinib—MAP2K5—liver—ulcerative colitis	0.000448	0.00219	CbGeAlD
Bosutinib—PLK2—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.000441	0.062	CbGdCrCtD
Bosutinib—CSF1R—liver—ulcerative colitis	0.000437	0.00213	CbGeAlD
Bosutinib—MAP4K4—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.000425	0.0598	CbGdCrCtD
Bosutinib—PDGFRB—liver—ulcerative colitis	0.000388	0.00189	CbGeAlD
Bosutinib—ABL1—liver—ulcerative colitis	0.000346	0.00169	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Methylprednisolone—ulcerative colitis	0.000337	0.0475	CbGdCrCtD
Bosutinib—Infestation—Methylprednisolone—ulcerative colitis	0.000334	0.00149	CcSEcCtD
Bosutinib—Chest pain—Mesalazine—ulcerative colitis	0.000333	0.00149	CcSEcCtD
Bosutinib—Myalgia—Mesalazine—ulcerative colitis	0.000333	0.00149	CcSEcCtD
Bosutinib—Arthralgia—Mesalazine—ulcerative colitis	0.000333	0.00149	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Betamethasone—ulcerative colitis	0.000332	0.0467	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Dexamethasone—ulcerative colitis	0.000332	0.0467	CbGdCrCtD
Bosutinib—Face oedema—Prednisone—ulcerative colitis	0.000332	0.00148	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000331	0.00148	CcSEcCtD
Bosutinib—Discomfort—Mesalazine—ulcerative colitis	0.000329	0.00147	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Triamcinolone—ulcerative colitis	0.000325	0.0456	CbGdCrCtD
Bosutinib—Feeling abnormal—Budesonide—ulcerative colitis	0.000323	0.00144	CcSEcCtD
Bosutinib—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000321	0.00143	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000319	0.00143	CcSEcCtD
Bosutinib—Oedema—Mesalazine—ulcerative colitis	0.000319	0.00143	CcSEcCtD
Bosutinib—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000319	0.00143	CcSEcCtD
Bosutinib—Infection—Mesalazine—ulcerative colitis	0.000317	0.00142	CcSEcCtD
Bosutinib—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000314	0.0014	CcSEcCtD
Bosutinib—Nervous system disorder—Mesalazine—ulcerative colitis	0.000313	0.0014	CcSEcCtD
Bosutinib—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000313	0.0014	CcSEcCtD
Bosutinib—Urticaria—Budesonide—ulcerative colitis	0.000312	0.00139	CcSEcCtD
Bosutinib—Abdominal pain—Budesonide—ulcerative colitis	0.00031	0.00139	CcSEcCtD
Bosutinib—Body temperature increased—Budesonide—ulcerative colitis	0.00031	0.00139	CcSEcCtD
Bosutinib—Skin disorder—Mesalazine—ulcerative colitis	0.00031	0.00138	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Prednisone—ulcerative colitis	0.000308	0.0433	CbGdCrCtD
Bosutinib—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000303	0.00135	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000303	0.00135	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Prednisolone—ulcerative colitis	0.000301	0.0423	CbGdCrCtD
Bosutinib—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000295	0.00132	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000291	0.0013	CcSEcCtD
Bosutinib—Feeling abnormal—Azathioprine—ulcerative colitis	0.000289	0.00129	CcSEcCtD
Bosutinib—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000289	0.00129	CcSEcCtD
Bosutinib—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000287	0.00128	CcSEcCtD
Bosutinib—Dyspnoea—Mesalazine—ulcerative colitis	0.000285	0.00127	CcSEcCtD
Bosutinib—Asthenia—Budesonide—ulcerative colitis	0.000282	0.00126	CcSEcCtD
Bosutinib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000279	0.00124	CcSEcCtD
Bosutinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000278	0.00124	CcSEcCtD
Bosutinib—Neutropenia—Prednisone—ulcerative colitis	0.000278	0.00124	CcSEcCtD
Bosutinib—Pruritus—Budesonide—ulcerative colitis	0.000278	0.00124	CcSEcCtD
Bosutinib—Decreased appetite—Mesalazine—ulcerative colitis	0.000278	0.00124	CcSEcCtD
Bosutinib—Body temperature increased—Azathioprine—ulcerative colitis	0.000277	0.00124	CcSEcCtD
Bosutinib—Abdominal pain—Azathioprine—ulcerative colitis	0.000277	0.00124	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000276	0.00123	CcSEcCtD
Bosutinib—Fatigue—Mesalazine—ulcerative colitis	0.000275	0.00123	CcSEcCtD
Bosutinib—Pain—Mesalazine—ulcerative colitis	0.000273	0.00122	CcSEcCtD
Bosutinib—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000271	0.00121	CcSEcCtD
Bosutinib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000271	0.00121	CcSEcCtD
Bosutinib—Diarrhoea—Budesonide—ulcerative colitis	0.000269	0.0012	CcSEcCtD
Bosutinib—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000264	0.00118	CcSEcCtD
Bosutinib—Feeling abnormal—Mesalazine—ulcerative colitis	0.000263	0.00117	CcSEcCtD
Bosutinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000261	0.00117	CcSEcCtD
Bosutinib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000261	0.00117	CcSEcCtD
Bosutinib—Dizziness—Budesonide—ulcerative colitis	0.00026	0.00116	CcSEcCtD
Bosutinib—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000258	0.00115	CcSEcCtD
Bosutinib—Malaise—Prednisolone—ulcerative colitis	0.000257	0.00115	CcSEcCtD
Bosutinib—Dysgeusia—Triamcinolone—ulcerative colitis	0.000256	0.00114	CcSEcCtD
Bosutinib—Urticaria—Mesalazine—ulcerative colitis	0.000254	0.00113	CcSEcCtD
Bosutinib—Back pain—Triamcinolone—ulcerative colitis	0.000253	0.00113	CcSEcCtD
Bosutinib—Abdominal pain—Mesalazine—ulcerative colitis	0.000252	0.00113	CcSEcCtD
Bosutinib—Body temperature increased—Mesalazine—ulcerative colitis	0.000252	0.00113	CcSEcCtD
Bosutinib—Malaise—Hydrocortisone—ulcerative colitis	0.000251	0.00112	CcSEcCtD
Bosutinib—Vomiting—Budesonide—ulcerative colitis	0.00025	0.00111	CcSEcCtD
Bosutinib—Rash—Budesonide—ulcerative colitis	0.000248	0.0011	CcSEcCtD
Bosutinib—Dermatitis—Budesonide—ulcerative colitis	0.000247	0.0011	CcSEcCtD
Bosutinib—Headache—Budesonide—ulcerative colitis	0.000246	0.0011	CcSEcCtD
Bosutinib—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000243	0.00108	CcSEcCtD
Bosutinib—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000242	0.00108	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Budesonide—ulcerative colitis	0.000241	0.034	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Budesonide—ulcerative colitis	0.000241	0.034	CbGdCrCtD
Bosutinib—Diarrhoea—Azathioprine—ulcerative colitis	0.00024	0.00107	CcSEcCtD
Bosutinib—Discomfort—Prednisolone—ulcerative colitis	0.00024	0.00107	CcSEcCtD
Bosutinib—Myalgia—Hydrocortisone—ulcerative colitis	0.000237	0.00106	CcSEcCtD
Bosutinib—Malaise—Triamcinolone—ulcerative colitis	0.000236	0.00105	CcSEcCtD
Bosutinib—Malaise—Methylprednisolone—ulcerative colitis	0.000236	0.00105	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000235	0.00105	CcSEcCtD
Bosutinib—Discomfort—Hydrocortisone—ulcerative colitis	0.000234	0.00104	CcSEcCtD
Bosutinib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000234	0.00104	CcSEcCtD
Bosutinib—Nausea—Budesonide—ulcerative colitis	0.000233	0.00104	CcSEcCtD
Bosutinib—Oedema—Prednisolone—ulcerative colitis	0.000232	0.00104	CcSEcCtD
Bosutinib—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000232	0.00104	CcSEcCtD
Bosutinib—Dizziness—Azathioprine—ulcerative colitis	0.000232	0.00103	CcSEcCtD
Bosutinib—Asthenia—Mesalazine—ulcerative colitis	0.000229	0.00102	CcSEcCtD
Bosutinib—Cough—Triamcinolone—ulcerative colitis	0.000229	0.00102	CcSEcCtD
Bosutinib—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000227	0.00101	CcSEcCtD
Bosutinib—Oedema—Hydrocortisone—ulcerative colitis	0.000227	0.00101	CcSEcCtD
Bosutinib—Pruritus—Mesalazine—ulcerative colitis	0.000226	0.00101	CcSEcCtD
Bosutinib—Infection—Hydrocortisone—ulcerative colitis	0.000226	0.00101	CcSEcCtD
Bosutinib—Myalgia—Triamcinolone—ulcerative colitis	0.000223	0.000995	CcSEcCtD
Bosutinib—Vomiting—Azathioprine—ulcerative colitis	0.000223	0.000995	CcSEcCtD
Bosutinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000223	0.000994	CcSEcCtD
Bosutinib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000222	0.000993	CcSEcCtD
Bosutinib—Myalgia—Methylprednisolone—ulcerative colitis	0.000222	0.000993	CcSEcCtD
Bosutinib—Rash—Azathioprine—ulcerative colitis	0.000221	0.000986	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000221	0.000986	CcSEcCtD
Bosutinib—Dermatitis—Azathioprine—ulcerative colitis	0.000221	0.000985	CcSEcCtD
Bosutinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000221	0.000984	CcSEcCtD
Bosutinib—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000221	0.000984	CcSEcCtD
Bosutinib—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000221	0.000984	CcSEcCtD
Bosutinib—Discomfort—Triamcinolone—ulcerative colitis	0.00022	0.000983	CcSEcCtD
Bosutinib—Discomfort—Methylprednisolone—ulcerative colitis	0.00022	0.000981	CcSEcCtD
Bosutinib—Headache—Azathioprine—ulcerative colitis	0.00022	0.00098	CcSEcCtD
Bosutinib—Diarrhoea—Mesalazine—ulcerative colitis	0.000218	0.000975	CcSEcCtD
Bosutinib—Immune system disorder—Prednisone—ulcerative colitis	0.000215	0.000959	CcSEcCtD
Bosutinib—Malaise—Dexamethasone—ulcerative colitis	0.000214	0.000957	CcSEcCtD
Bosutinib—Malaise—Betamethasone—ulcerative colitis	0.000214	0.000957	CcSEcCtD
Bosutinib—Oedema—Triamcinolone—ulcerative colitis	0.000214	0.000954	CcSEcCtD
Bosutinib—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000214	0.000954	CcSEcCtD
Bosutinib—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000213	0.000952	CcSEcCtD
Bosutinib—Infection—Triamcinolone—ulcerative colitis	0.000212	0.000948	CcSEcCtD
Bosutinib—Infection—Methylprednisolone—ulcerative colitis	0.000212	0.000946	CcSEcCtD
Bosutinib—Dizziness—Mesalazine—ulcerative colitis	0.000211	0.000942	CcSEcCtD
Bosutinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000209	0.000934	CcSEcCtD
Bosutinib—Nausea—Azathioprine—ulcerative colitis	0.000208	0.000929	CcSEcCtD
Bosutinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000207	0.000925	CcSEcCtD
Bosutinib—Malnutrition—Prednisone—ulcerative colitis	0.000207	0.000924	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000207	0.000923	CcSEcCtD
Bosutinib—CYP3A4—digestive system—ulcerative colitis	0.000204	0.000995	CbGeAlD
Bosutinib—Vomiting—Mesalazine—ulcerative colitis	0.000203	0.000906	CcSEcCtD
Bosutinib—PKMYT1—Danazol—Hydrocortisone—ulcerative colitis	0.000203	0.0285	CbGdCrCtD
Bosutinib—Myalgia—Betamethasone—ulcerative colitis	0.000202	0.000903	CcSEcCtD
Bosutinib—Myalgia—Dexamethasone—ulcerative colitis	0.000202	0.000903	CcSEcCtD
Bosutinib—Rash—Mesalazine—ulcerative colitis	0.000201	0.000899	CcSEcCtD
Bosutinib—Dermatitis—Mesalazine—ulcerative colitis	0.000201	0.000898	CcSEcCtD
Bosutinib—Headache—Mesalazine—ulcerative colitis	0.0002	0.000893	CcSEcCtD
Bosutinib—Discomfort—Dexamethasone—ulcerative colitis	0.0002	0.000892	CcSEcCtD
Bosutinib—Discomfort—Betamethasone—ulcerative colitis	0.0002	0.000892	CcSEcCtD
Bosutinib—Pain—Prednisolone—ulcerative colitis	0.000199	0.000887	CcSEcCtD
Bosutinib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000197	0.000881	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000196	0.000875	CcSEcCtD
Bosutinib—Fatigue—Hydrocortisone—ulcerative colitis	0.000196	0.000874	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000195	0.000869	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000194	0.000867	CcSEcCtD
Bosutinib—Pain—Hydrocortisone—ulcerative colitis	0.000194	0.000867	CcSEcCtD
Bosutinib—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000194	0.000866	CcSEcCtD
Bosutinib—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000194	0.000866	CcSEcCtD
Bosutinib—Oedema—Dexamethasone—ulcerative colitis	0.000194	0.000866	CcSEcCtD
Bosutinib—Oedema—Betamethasone—ulcerative colitis	0.000194	0.000866	CcSEcCtD
Bosutinib—CSNK1E—Danazol—Hydrocortisone—ulcerative colitis	0.000194	0.0272	CbGdCrCtD
Bosutinib—Infection—Betamethasone—ulcerative colitis	0.000193	0.00086	CcSEcCtD
Bosutinib—Infection—Dexamethasone—ulcerative colitis	0.000193	0.00086	CcSEcCtD
Bosutinib—Ill-defined disorder—Prednisone—ulcerative colitis	0.000192	0.000857	CcSEcCtD
Bosutinib—Feeling abnormal—Prednisolone—ulcerative colitis	0.000192	0.000855	CcSEcCtD
Bosutinib—Anaemia—Prednisone—ulcerative colitis	0.000191	0.000854	CcSEcCtD
Bosutinib—Dyspnoea—Triamcinolone—ulcerative colitis	0.000191	0.000851	CcSEcCtD
Bosutinib—Nervous system disorder—Betamethasone—ulcerative colitis	0.00019	0.000849	CcSEcCtD
Bosutinib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00019	0.000849	CcSEcCtD
Bosutinib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.00019	0.000848	CcSEcCtD
Bosutinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.00019	0.000848	CcSEcCtD
Bosutinib—Nausea—Mesalazine—ulcerative colitis	0.00019	0.000846	CcSEcCtD
Bosutinib—ABCB1—epithelium—ulcerative colitis	0.00019	0.000926	CbGeAlD
Bosutinib—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000187	0.000835	CcSEcCtD
Bosutinib—Malaise—Prednisone—ulcerative colitis	0.000187	0.000833	CcSEcCtD
Bosutinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000186	0.000829	CcSEcCtD
Bosutinib—Urticaria—Prednisolone—ulcerative colitis	0.000185	0.000824	CcSEcCtD
Bosutinib—Fatigue—Triamcinolone—ulcerative colitis	0.000184	0.000823	CcSEcCtD
Bosutinib—Fatigue—Methylprednisolone—ulcerative colitis	0.000184	0.000821	CcSEcCtD
Bosutinib—Pain—Triamcinolone—ulcerative colitis	0.000183	0.000816	CcSEcCtD
Bosutinib—Urticaria—Hydrocortisone—ulcerative colitis	0.00018	0.000805	CcSEcCtD
Bosutinib—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000179	0.000801	CcSEcCtD
Bosutinib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000179	0.000801	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000177	0.000789	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000177	0.000789	CcSEcCtD
Bosutinib—Arthralgia—Prednisone—ulcerative colitis	0.000176	0.000786	CcSEcCtD
Bosutinib—Myalgia—Prednisone—ulcerative colitis	0.000176	0.000786	CcSEcCtD
Bosutinib—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000176	0.000786	CcSEcCtD
Bosutinib—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000176	0.000785	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000175	0.000781	CcSEcCtD
Bosutinib—PKMYT1—Danazol—Prednisone—ulcerative colitis	0.000175	0.0246	CbGdCrCtD
Bosutinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000174	0.000778	CcSEcCtD
Bosutinib—Discomfort—Prednisone—ulcerative colitis	0.000174	0.000777	CcSEcCtD
Bosutinib—Urticaria—Triamcinolone—ulcerative colitis	0.00017	0.000758	CcSEcCtD
Bosutinib—Urticaria—Methylprednisolone—ulcerative colitis	0.000169	0.000756	CcSEcCtD
Bosutinib—Body temperature increased—Triamcinolone—ulcerative colitis	0.000169	0.000754	CcSEcCtD
Bosutinib—Oedema—Prednisone—ulcerative colitis	0.000169	0.000754	CcSEcCtD
Bosutinib—Anaphylactic shock—Prednisone—ulcerative colitis	0.000169	0.000754	CcSEcCtD
Bosutinib—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000169	0.000753	CcSEcCtD
Bosutinib—Decreased appetite—Dexamethasone—ulcerative colitis	0.000169	0.000753	CcSEcCtD
Bosutinib—Decreased appetite—Betamethasone—ulcerative colitis	0.000169	0.000753	CcSEcCtD
Bosutinib—Infection—Prednisone—ulcerative colitis	0.000168	0.000749	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000167	0.000747	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000167	0.000747	CcSEcCtD
Bosutinib—Fatigue—Dexamethasone—ulcerative colitis	0.000167	0.000746	CcSEcCtD
Bosutinib—Fatigue—Betamethasone—ulcerative colitis	0.000167	0.000746	CcSEcCtD
Bosutinib—CSNK1E—Danazol—Prednisone—ulcerative colitis	0.000167	0.0234	CbGdCrCtD
Bosutinib—Pain—Betamethasone—ulcerative colitis	0.000166	0.00074	CcSEcCtD
Bosutinib—Pain—Dexamethasone—ulcerative colitis	0.000166	0.00074	CcSEcCtD
Bosutinib—Nervous system disorder—Prednisone—ulcerative colitis	0.000166	0.000739	CcSEcCtD
Bosutinib—Skin disorder—Prednisone—ulcerative colitis	0.000164	0.000732	CcSEcCtD
Bosutinib—Asthenia—Hydrocortisone—ulcerative colitis	0.000163	0.000727	CcSEcCtD
Bosutinib—Pruritus—Hydrocortisone—ulcerative colitis	0.000161	0.000717	CcSEcCtD
Bosutinib—Feeling abnormal—Betamethasone—ulcerative colitis	0.00016	0.000713	CcSEcCtD
Bosutinib—Feeling abnormal—Dexamethasone—ulcerative colitis	0.00016	0.000713	CcSEcCtD
Bosutinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000159	0.000708	CcSEcCtD
Bosutinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000159	0.000708	CcSEcCtD
Bosutinib—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000155	0.000693	CcSEcCtD
Bosutinib—Urticaria—Betamethasone—ulcerative colitis	0.000154	0.000688	CcSEcCtD
Bosutinib—Urticaria—Dexamethasone—ulcerative colitis	0.000154	0.000688	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000154	0.000687	CcSEcCtD
Bosutinib—Dizziness—Prednisolone—ulcerative colitis	0.000154	0.000686	CcSEcCtD
Bosutinib—Asthenia—Triamcinolone—ulcerative colitis	0.000153	0.000685	CcSEcCtD
Bosutinib—Body temperature increased—Betamethasone—ulcerative colitis	0.000153	0.000684	CcSEcCtD
Bosutinib—Abdominal pain—Dexamethasone—ulcerative colitis	0.000153	0.000684	CcSEcCtD
Bosutinib—Body temperature increased—Dexamethasone—ulcerative colitis	0.000153	0.000684	CcSEcCtD
Bosutinib—Abdominal pain—Betamethasone—ulcerative colitis	0.000153	0.000684	CcSEcCtD
Bosutinib—Asthenia—Methylprednisolone—ulcerative colitis	0.000153	0.000683	CcSEcCtD
Bosutinib—CYP3A4—liver—ulcerative colitis	0.000152	0.000741	CbGeAlD
Bosutinib—Pruritus—Triamcinolone—ulcerative colitis	0.000151	0.000675	CcSEcCtD
Bosutinib—Pruritus—Methylprednisolone—ulcerative colitis	0.000151	0.000674	CcSEcCtD
Bosutinib—Dizziness—Hydrocortisone—ulcerative colitis	0.00015	0.00067	CcSEcCtD
Bosutinib—Decreased appetite—Prednisone—ulcerative colitis	0.000147	0.000655	CcSEcCtD
Bosutinib—Rash—Prednisolone—ulcerative colitis	0.000147	0.000654	CcSEcCtD
Bosutinib—Dermatitis—Prednisolone—ulcerative colitis	0.000146	0.000654	CcSEcCtD
Bosutinib—ABCB1—lymphoid tissue—ulcerative colitis	0.000146	0.000713	CbGeAlD
Bosutinib—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000146	0.000651	CcSEcCtD
Bosutinib—Fatigue—Prednisone—ulcerative colitis	0.000146	0.00065	CcSEcCtD
Bosutinib—Headache—Prednisolone—ulcerative colitis	0.000146	0.00065	CcSEcCtD
Bosutinib—Vomiting—Hydrocortisone—ulcerative colitis	0.000144	0.000644	CcSEcCtD
Bosutinib—ABCB1—digestive system—ulcerative colitis	0.000144	0.000704	CbGeAlD
Bosutinib—Rash—Hydrocortisone—ulcerative colitis	0.000143	0.000639	CcSEcCtD
Bosutinib—Dermatitis—Hydrocortisone—ulcerative colitis	0.000143	0.000638	CcSEcCtD
Bosutinib—Headache—Hydrocortisone—ulcerative colitis	0.000142	0.000635	CcSEcCtD
Bosutinib—Dizziness—Triamcinolone—ulcerative colitis	0.000141	0.000631	CcSEcCtD
Bosutinib—Dizziness—Methylprednisolone—ulcerative colitis	0.000141	0.00063	CcSEcCtD
Bosutinib—Feeling abnormal—Prednisone—ulcerative colitis	0.000139	0.000621	CcSEcCtD
Bosutinib—Asthenia—Dexamethasone—ulcerative colitis	0.000139	0.000621	CcSEcCtD
Bosutinib—Asthenia—Betamethasone—ulcerative colitis	0.000139	0.000621	CcSEcCtD
Bosutinib—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000138	0.000617	CcSEcCtD
Bosutinib—Nausea—Prednisolone—ulcerative colitis	0.000138	0.000616	CcSEcCtD
Bosutinib—Pruritus—Dexamethasone—ulcerative colitis	0.000137	0.000613	CcSEcCtD
Bosutinib—Pruritus—Betamethasone—ulcerative colitis	0.000137	0.000613	CcSEcCtD
Bosutinib—Vomiting—Triamcinolone—ulcerative colitis	0.000136	0.000607	CcSEcCtD
Bosutinib—Vomiting—Methylprednisolone—ulcerative colitis	0.000136	0.000605	CcSEcCtD
Bosutinib—Nausea—Hydrocortisone—ulcerative colitis	0.000135	0.000602	CcSEcCtD
Bosutinib—Rash—Triamcinolone—ulcerative colitis	0.000135	0.000602	CcSEcCtD
Bosutinib—Dermatitis—Triamcinolone—ulcerative colitis	0.000135	0.000601	CcSEcCtD
Bosutinib—Rash—Methylprednisolone—ulcerative colitis	0.000134	0.0006	CcSEcCtD
Bosutinib—Dermatitis—Methylprednisolone—ulcerative colitis	0.000134	0.0006	CcSEcCtD
Bosutinib—Urticaria—Prednisone—ulcerative colitis	0.000134	0.000599	CcSEcCtD
Bosutinib—Headache—Triamcinolone—ulcerative colitis	0.000134	0.000598	CcSEcCtD
Bosutinib—Headache—Methylprednisolone—ulcerative colitis	0.000134	0.000596	CcSEcCtD
Bosutinib—Body temperature increased—Prednisone—ulcerative colitis	0.000134	0.000596	CcSEcCtD
Bosutinib—Abdominal pain—Prednisone—ulcerative colitis	0.000134	0.000596	CcSEcCtD
Bosutinib—Diarrhoea—Betamethasone—ulcerative colitis	0.000133	0.000592	CcSEcCtD
Bosutinib—Diarrhoea—Dexamethasone—ulcerative colitis	0.000133	0.000592	CcSEcCtD
Bosutinib—Dizziness—Betamethasone—ulcerative colitis	0.000128	0.000573	CcSEcCtD
Bosutinib—Dizziness—Dexamethasone—ulcerative colitis	0.000128	0.000573	CcSEcCtD
Bosutinib—Nausea—Triamcinolone—ulcerative colitis	0.000127	0.000567	CcSEcCtD
Bosutinib—Nausea—Methylprednisolone—ulcerative colitis	0.000127	0.000565	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Hydrocortisone—ulcerative colitis	0.000124	0.0174	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000124	0.0174	CbGdCrCtD
Bosutinib—Vomiting—Betamethasone—ulcerative colitis	0.000123	0.00055	CcSEcCtD
Bosutinib—Vomiting—Dexamethasone—ulcerative colitis	0.000123	0.00055	CcSEcCtD
Bosutinib—Rash—Betamethasone—ulcerative colitis	0.000122	0.000546	CcSEcCtD
Bosutinib—Rash—Dexamethasone—ulcerative colitis	0.000122	0.000546	CcSEcCtD
Bosutinib—Dermatitis—Dexamethasone—ulcerative colitis	0.000122	0.000545	CcSEcCtD
Bosutinib—Dermatitis—Betamethasone—ulcerative colitis	0.000122	0.000545	CcSEcCtD
Bosutinib—Headache—Betamethasone—ulcerative colitis	0.000122	0.000542	CcSEcCtD
Bosutinib—Headache—Dexamethasone—ulcerative colitis	0.000122	0.000542	CcSEcCtD
Bosutinib—Asthenia—Prednisone—ulcerative colitis	0.000121	0.000541	CcSEcCtD
Bosutinib—Pruritus—Prednisone—ulcerative colitis	0.00012	0.000533	CcSEcCtD
Bosutinib—CHEK2—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.000119	0.0168	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000117	0.0164	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Methylprednisolone—ulcerative colitis	0.000117	0.0164	CbGdCrCtD
Bosutinib—Diarrhoea—Prednisone—ulcerative colitis	0.000116	0.000516	CcSEcCtD
Bosutinib—Nausea—Dexamethasone—ulcerative colitis	0.000115	0.000514	CcSEcCtD
Bosutinib—Nausea—Betamethasone—ulcerative colitis	0.000115	0.000514	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Dexamethasone—ulcerative colitis	0.000115	0.0161	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Betamethasone—ulcerative colitis	0.000115	0.0161	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Triamcinolone—ulcerative colitis	0.000112	0.0158	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Triamcinolone—ulcerative colitis	0.000112	0.0158	CbGdCrCtD
Bosutinib—Dizziness—Prednisone—ulcerative colitis	0.000112	0.000499	CcSEcCtD
Bosutinib—ABCB1—liver—ulcerative colitis	0.000107	0.000525	CbGeAlD
Bosutinib—Vomiting—Prednisone—ulcerative colitis	0.000107	0.000479	CcSEcCtD
Bosutinib—Rash—Prednisone—ulcerative colitis	0.000107	0.000475	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Prednisone—ulcerative colitis	0.000106	0.015	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisone—ulcerative colitis	0.000106	0.015	CbGdCrCtD
Bosutinib—Dermatitis—Prednisone—ulcerative colitis	0.000106	0.000475	CcSEcCtD
Bosutinib—Headache—Prednisone—ulcerative colitis	0.000106	0.000472	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Prednisolone—ulcerative colitis	0.000104	0.0146	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisolone—ulcerative colitis	0.000104	0.0146	CbGdCrCtD
Bosutinib—Nausea—Prednisone—ulcerative colitis	0.0001	0.000448	CcSEcCtD
Bosutinib—CHEK2—Danazol—Hydrocortisone—ulcerative colitis	9.91e-05	0.0139	CbGdCrCtD
Bosutinib—CHEK2—Norethindrone—Hydrocortisone—ulcerative colitis	8.93e-05	0.0126	CbGdCrCtD
Bosutinib—CHEK2—Danazol—Prednisone—ulcerative colitis	8.53e-05	0.012	CbGdCrCtD
Bosutinib—CHEK2—Levonorgestrel—Hydrocortisone—ulcerative colitis	7.11e-05	0.00999	CbGdCrCtD
Bosutinib—SRC—Immune System—CDH1—ulcerative colitis	3.18e-06	7.61e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—RELA—ulcerative colitis	3.16e-06	7.57e-06	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL6—ulcerative colitis	3.16e-06	7.56e-06	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL6—ulcerative colitis	3.16e-06	7.56e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—JAK2—ulcerative colitis	3.16e-06	7.56e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—STAT3—ulcerative colitis	3.16e-06	7.56e-06	CbGpPWpGaD
Bosutinib—ERBB4—Disease—IL6—ulcerative colitis	3.15e-06	7.54e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—JAK2—ulcerative colitis	3.15e-06	7.53e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—NFKB1—ulcerative colitis	3.13e-06	7.5e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MMP9—ulcerative colitis	3.13e-06	7.49e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	3.13e-06	7.49e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—NFKB1—ulcerative colitis	3.12e-06	7.47e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL2—ulcerative colitis	3.12e-06	7.46e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—STAT3—ulcerative colitis	3.11e-06	7.45e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—NFKB1—ulcerative colitis	3.1e-06	7.41e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—ulcerative colitis	3.09e-06	7.41e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IFNG—ulcerative colitis	3.09e-06	7.39e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—NFKB1—ulcerative colitis	3.09e-06	7.39e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CXCL8—ulcerative colitis	3.08e-06	7.37e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—NFKB1—ulcerative colitis	3.07e-06	7.35e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—RELA—ulcerative colitis	3.06e-06	7.32e-06	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL6—ulcerative colitis	3.05e-06	7.3e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—RELA—ulcerative colitis	3.05e-06	7.29e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CXCL8—ulcerative colitis	3.04e-06	7.27e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—JAK2—ulcerative colitis	3.01e-06	7.22e-06	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL6—ulcerative colitis	3.01e-06	7.2e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—STAT3—ulcerative colitis	3e-06	7.17e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—ulcerative colitis	2.98e-06	7.14e-06	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TP53—ulcerative colitis	2.97e-06	7.12e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—JAK2—ulcerative colitis	2.97e-06	7.11e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—STAT3—ulcerative colitis	2.95e-06	7.06e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL2—ulcerative colitis	2.94e-06	7.05e-06	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.93e-06	7e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFB1—ulcerative colitis	2.93e-06	7e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—JAK2—ulcerative colitis	2.9e-06	6.95e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—ulcerative colitis	2.9e-06	6.95e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADCY5—ulcerative colitis	2.89e-06	6.91e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—STAT3—ulcerative colitis	2.89e-06	6.91e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—STAT3—ulcerative colitis	2.89e-06	6.91e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—ulcerative colitis	2.88e-06	6.9e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CXCL8—ulcerative colitis	2.88e-06	6.9e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—RELA—ulcerative colitis	2.88e-06	6.89e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—STAT3—ulcerative colitis	2.88e-06	6.89e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—ulcerative colitis	2.87e-06	6.88e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—ulcerative colitis	2.86e-06	6.84e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—ulcerative colitis	2.86e-06	6.84e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—ulcerative colitis	2.85e-06	6.82e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—ulcerative colitis	2.84e-06	6.79e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—STAT3—ulcerative colitis	2.82e-06	6.74e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CALM3—ulcerative colitis	2.82e-06	6.74e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—STAT3—ulcerative colitis	2.8e-06	6.71e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TP53—ulcerative colitis	2.79e-06	6.67e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MMP9—ulcerative colitis	2.79e-06	6.67e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—JAK2—ulcerative colitis	2.78e-06	6.67e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—STAT3—ulcerative colitis	2.78e-06	6.66e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—ulcerative colitis	2.78e-06	6.65e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—ulcerative colitis	2.78e-06	6.64e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—ulcerative colitis	2.77e-06	6.64e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—STAT3—ulcerative colitis	2.77e-06	6.64e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—ulcerative colitis	2.77e-06	6.63e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—STAT3—ulcerative colitis	2.76e-06	6.6e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NFKB1—ulcerative colitis	2.76e-06	6.6e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—ulcerative colitis	2.75e-06	6.59e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—ulcerative colitis	2.75e-06	6.59e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—ulcerative colitis	2.75e-06	6.59e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MMP9—ulcerative colitis	2.75e-06	6.58e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—ulcerative colitis	2.74e-06	6.57e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—ulcerative colitis	2.73e-06	6.54e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—ulcerative colitis	2.73e-06	6.54e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—STAT3—ulcerative colitis	2.72e-06	6.52e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NFKB1—ulcerative colitis	2.72e-06	6.51e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CXCL8—ulcerative colitis	2.71e-06	6.49e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—RELA—ulcerative colitis	2.7e-06	6.46e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—ulcerative colitis	2.68e-06	6.41e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—ulcerative colitis	2.68e-06	6.41e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—ulcerative colitis	2.68e-06	6.41e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NFKB1—ulcerative colitis	2.67e-06	6.38e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—STAT3—ulcerative colitis	2.66e-06	6.36e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—ulcerative colitis	2.64e-06	6.32e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—ulcerative colitis	2.64e-06	6.32e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—ulcerative colitis	2.61e-06	6.24e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—JAK2—ulcerative colitis	2.6e-06	6.22e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—ulcerative colitis	2.59e-06	6.21e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—ulcerative colitis	2.58e-06	6.17e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NFKB1—ulcerative colitis	2.58e-06	6.17e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—JAK2—ulcerative colitis	2.57e-06	6.16e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—NFKB1—ulcerative colitis	2.57e-06	6.15e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—STAT3—ulcerative colitis	2.56e-06	6.13e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—ulcerative colitis	2.55e-06	6.11e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—STAT3—ulcerative colitis	2.55e-06	6.1e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—JAK2—ulcerative colitis	2.53e-06	6.07e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—ulcerative colitis	2.52e-06	6.04e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—RELA—ulcerative colitis	2.51e-06	6.02e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—ulcerative colitis	2.5e-06	5.99e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—JAK2—ulcerative colitis	2.48e-06	5.94e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—STAT3—ulcerative colitis	2.48e-06	5.93e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—ulcerative colitis	2.46e-06	5.89e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—RELA—ulcerative colitis	2.45e-06	5.88e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—ulcerative colitis	2.45e-06	5.87e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—ulcerative colitis	2.45e-06	5.87e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—JAK2—ulcerative colitis	2.44e-06	5.85e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—STAT3—ulcerative colitis	2.44e-06	5.85e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—ulcerative colitis	2.44e-06	5.84e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—ulcerative colitis	2.44e-06	5.84e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—JAK2—ulcerative colitis	2.43e-06	5.82e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—ulcerative colitis	2.43e-06	5.82e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NFKB1—ulcerative colitis	2.43e-06	5.81e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—ulcerative colitis	2.42e-06	5.79e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TP53—ulcerative colitis	2.41e-06	5.77e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—RELA—ulcerative colitis	2.4e-06	5.75e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—STAT3—ulcerative colitis	2.4e-06	5.74e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TP53—ulcerative colitis	2.37e-06	5.68e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—ulcerative colitis	2.37e-06	5.68e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CXCL8—ulcerative colitis	2.37e-06	5.67e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—RELA—ulcerative colitis	2.37e-06	5.66e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—ulcerative colitis	2.36e-06	5.65e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—ulcerative colitis	2.36e-06	5.64e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—RELA—ulcerative colitis	2.35e-06	5.63e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—STAT3—ulcerative colitis	2.32e-06	5.55e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CXCL8—ulcerative colitis	2.31e-06	5.54e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—STAT3—ulcerative colitis	2.31e-06	5.53e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—ulcerative colitis	2.3e-06	5.5e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TP53—ulcerative colitis	2.29e-06	5.47e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—NFKB1—ulcerative colitis	2.27e-06	5.45e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—ulcerative colitis	2.26e-06	5.42e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CXCL8—ulcerative colitis	2.26e-06	5.42e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—ulcerative colitis	2.26e-06	5.42e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—ulcerative colitis	2.25e-06	5.4e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CXCL8—ulcerative colitis	2.23e-06	5.34e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CXCL8—ulcerative colitis	2.22e-06	5.31e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—STAT3—ulcerative colitis	2.21e-06	5.3e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—ulcerative colitis	2.21e-06	5.29e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—ulcerative colitis	2.2e-06	5.28e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TP53—ulcerative colitis	2.2e-06	5.27e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TP53—ulcerative colitis	2.2e-06	5.27e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—STAT3—ulcerative colitis	2.18e-06	5.22e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—ulcerative colitis	2.17e-06	5.2e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—ulcerative colitis	2.16e-06	5.18e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—ulcerative colitis	2.15e-06	5.14e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—ulcerative colitis	2.14e-06	5.13e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—STAT3—ulcerative colitis	2.13e-06	5.1e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—ulcerative colitis	2.13e-06	5.1e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TP53—ulcerative colitis	2.12e-06	5.08e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NFKB1—ulcerative colitis	2.12e-06	5.08e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—ulcerative colitis	2.12e-06	5.07e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—JAK2—ulcerative colitis	2.11e-06	5.05e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—ulcerative colitis	2.11e-06	5.05e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—ulcerative colitis	2.09e-06	5.01e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—ulcerative colitis	2.09e-06	5.01e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NFKB1—ulcerative colitis	2.07e-06	4.96e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—ulcerative colitis	2.06e-06	4.93e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—ulcerative colitis	2.05e-06	4.91e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—ulcerative colitis	2.05e-06	4.9e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—STAT3—ulcerative colitis	2.04e-06	4.89e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RELA—ulcerative colitis	2.04e-06	4.89e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	2.04e-06	4.89e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—JAK2—ulcerative colitis	2.03e-06	4.87e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NFKB1—ulcerative colitis	2.03e-06	4.85e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—ulcerative colitis	2.02e-06	4.84e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—ulcerative colitis	2.02e-06	4.83e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—ulcerative colitis	2.02e-06	4.83e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—ulcerative colitis	2.02e-06	4.83e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—ulcerative colitis	2.01e-06	4.81e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—ulcerative colitis	2.01e-06	4.8e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NFKB1—ulcerative colitis	1.99e-06	4.78e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NFKB1—ulcerative colitis	1.98e-06	4.75e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—ulcerative colitis	1.98e-06	4.73e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RELA—ulcerative colitis	1.97e-06	4.72e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—ulcerative colitis	1.97e-06	4.71e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—ulcerative colitis	1.96e-06	4.69e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—ulcerative colitis	1.94e-06	4.65e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—ulcerative colitis	1.94e-06	4.64e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.93e-06	4.61e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—ulcerative colitis	1.93e-06	4.61e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—ulcerative colitis	1.93e-06	4.61e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—STAT3—ulcerative colitis	1.91e-06	4.56e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—ulcerative colitis	1.9e-06	4.55e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TP53—ulcerative colitis	1.89e-06	4.52e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—STAT3—ulcerative colitis	1.89e-06	4.52e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TP53—ulcerative colitis	1.86e-06	4.46e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—STAT3—ulcerative colitis	1.86e-06	4.45e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—ulcerative colitis	1.86e-06	4.44e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—ulcerative colitis	1.86e-06	4.44e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—ulcerative colitis	1.84e-06	4.41e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—ulcerative colitis	1.83e-06	4.39e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—STAT3—ulcerative colitis	1.82e-06	4.36e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—JAK2—ulcerative colitis	1.8e-06	4.31e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—STAT3—ulcerative colitis	1.79e-06	4.29e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—ulcerative colitis	1.79e-06	4.28e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—STAT3—ulcerative colitis	1.78e-06	4.27e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—ulcerative colitis	1.78e-06	4.26e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—ulcerative colitis	1.77e-06	4.25e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TP53—ulcerative colitis	1.77e-06	4.23e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—ulcerative colitis	1.77e-06	4.23e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—ulcerative colitis	1.75e-06	4.19e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RELA—ulcerative colitis	1.74e-06	4.17e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—ulcerative colitis	1.74e-06	4.17e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.74e-06	4.15e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—ulcerative colitis	1.73e-06	4.14e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—ulcerative colitis	1.72e-06	4.13e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NFKB1—ulcerative colitis	1.72e-06	4.13e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—ulcerative colitis	1.71e-06	4.08e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—ulcerative colitis	1.69e-06	4.04e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—ulcerative colitis	1.68e-06	4.02e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—ulcerative colitis	1.67e-06	4.01e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TP53—ulcerative colitis	1.66e-06	3.98e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—ulcerative colitis	1.66e-06	3.98e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NFKB1—ulcerative colitis	1.66e-06	3.98e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—ulcerative colitis	1.65e-06	3.96e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—ulcerative colitis	1.64e-06	3.93e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—ulcerative colitis	1.62e-06	3.87e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—ulcerative colitis	1.61e-06	3.86e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—ulcerative colitis	1.57e-06	3.76e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—STAT3—ulcerative colitis	1.55e-06	3.71e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—ulcerative colitis	1.54e-06	3.7e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARG—ulcerative colitis	1.52e-06	3.65e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—ulcerative colitis	1.52e-06	3.65e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—STAT3—ulcerative colitis	1.49e-06	3.57e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—ulcerative colitis	1.49e-06	3.56e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—ulcerative colitis	1.49e-06	3.56e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NFKB1—ulcerative colitis	1.47e-06	3.52e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TP53—ulcerative colitis	1.45e-06	3.48e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—ulcerative colitis	1.44e-06	3.44e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—ulcerative colitis	1.43e-06	3.42e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TP53—ulcerative colitis	1.42e-06	3.4e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TP53—ulcerative colitis	1.39e-06	3.33e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—ulcerative colitis	1.38e-06	3.31e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—ulcerative colitis	1.37e-06	3.28e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TP53—ulcerative colitis	1.37e-06	3.28e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TP53—ulcerative colitis	1.36e-06	3.26e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.35e-06	3.23e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—ulcerative colitis	1.33e-06	3.19e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—STAT3—ulcerative colitis	1.32e-06	3.16e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—ulcerative colitis	1.32e-06	3.16e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—ulcerative colitis	1.3e-06	3.11e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—ulcerative colitis	1.27e-06	3.05e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.26e-06	3.01e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—ulcerative colitis	1.25e-06	3e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—ulcerative colitis	1.25e-06	2.98e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—ulcerative colitis	1.22e-06	2.93e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.2e-06	2.87e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TP53—ulcerative colitis	1.18e-06	2.83e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TP53—ulcerative colitis	1.14e-06	2.73e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—ulcerative colitis	1.08e-06	2.59e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—ulcerative colitis	1.04e-06	2.5e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TP53—ulcerative colitis	1.01e-06	2.41e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	9.39e-07	2.25e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—ulcerative colitis	9.23e-07	2.21e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—ulcerative colitis	8.44e-07	2.02e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.39e-07	1.77e-06	CbGpPWpGaD
